From Mendel to Medical Genetics: Milan Macek Jr. to Share Rare Disease Insights at ECTH 2025
European Congress on Thrombosis and Haemostasis (ECTH) posted on LinkedIn:
”From the legacy of Mendel to the frontlines of rare disease advocacy, Professor Milan Macek Jr., MD, DSc, is a true pioneer in medical genetics. As chair of the Czech Republic’s largest academic genetics centre and head of the National Coordination Centre for Rare Diseases, he’s shaping not just science, but national health strategies.
At ECTH 2025, Professor Milan Macek Jr. will take us on a journey through his session “From Mendel to medical genetics”, exploring how genetic breakthroughs are transforming diagnostics, care, and policy for rare diseases.
Expect a session that’s as visionary as it is practical; bridging history, cutting-edge research, and the real-world impact of coordinated action.
Join us at ECTH 2025.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation